© Reuters. Picture illustration of vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels

LONDON (Reuters) -Pregnant women in Britain should get a COVID-19 vaccine made by Pfizer (NYSE:) or Moderna (NASDAQ:) because there is more real-world data to show they are safe, the British public body that advises on vaccinations said on Friday.

The Joint Committee on Vaccination and Immunisation (JCVI) said around 90,000 pregnant women had been vaccinated in the United States, mainly with the two American vaccines, without any safety concerns being raised.

“Based on these data, the JCVI advises that it is preferable for pregnant women in the UK to be offered the Pfizer-BioNTech or Moderna vaccines where available,” it said. “There is no evidence to suggest that other vaccines are unsafe for pregnant women, but more research is needed.”

Pregnant women had previously been advised against taking the vaccine in Britain because not enough information was known about the impact.

“I encourage all pregnant women when they are called to get the jab to come forward and discuss the benefits and risks of the vaccine with a trusted source like their GP (family doctor), obstetrician or midwife,” Health Secretary Matt Hancock said.

Britain recently advised that all under 30s should be given alternative vaccines to the Oxford/AstraZeneca shot if possible because of a “vanishingly” rare side effect of blood clots in the brain.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

READ  Johnson, Sunak agree to extend universal credit benefit - The Times

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Please enter your comment!
Please enter your name here